Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV) (087LATAMFIV)
Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Systane ® Ultra Preservative Free on Tear Film Dysfunction Syndrome From Mild to Moderate
Sponsor: Laboratorios Sophia S.A de C.V.
A PHASE4 clinical study on Dry Eye Syndrome, this trial is completed. The trial is conducted by Laboratorios Sophia S.A de C.V. and has accumulated 7 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Nov 2019 — Jan 2021 [monthly]
Completed PHASE4
-
Jun 2019 — Nov 2019 [monthly]
Completed PHASE4
Status: Recruiting → Completed
▶ Show 2 earlier versions
-
Jun 2018 — Jun 2019 [monthly]
Recruiting PHASE4
-
Aug 2017 — Jun 2018 [monthly]
Recruiting PHASE4
First recorded
Oct 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Laboratorios Sophia S.A de C.V.
For direct contact, visit the study record on ClinicalTrials.gov .